American Journal of Translational Research-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1183089, encodeId=a0ca118308919, content=有老哥知道吗，为啥一提交，直接显示under review啊,没有编辑处理的过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9925193263, createdName=1471fd32m50暂无昵称, createdTime=Tue Jan 11 08:57:31 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238801, encodeId=c12c123880186, content=有哪位前辈分享一下微生物临床研究Q3的2-3分的杂志啊，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66495497077, createdName=Ysbstsvshndudnd, createdTime=Mon Aug 15 14:41:37 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222243, encodeId=7f7b1222243e5, content=审稿速度:3.0 | 投稿命中率:50.0 | 影响因子:4.06 偏重的研究方向：肿瘤免疫微环境;肿瘤;免疫检查点 经验分享：经历8个月，修了2次，因为疫情耽误了2个月，发了4次Reminder letter，昨天接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f425184724, createdName=14704397m27暂无昵称, createdTime=Wed May 25 08:58:04 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969139, encodeId=ad1196913910, content=生信期刊收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epbiavQw9picXSMXa5H7ZG9oW2IUumIqEJffFK1qfw7FS2XODCYRNmp6YlLwywwIZ2zxRVfGY0XHEnw/132, createdBy=67992544404, createdName=哈哈娜, createdTime=Fri May 28 10:54:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051478, encodeId=fa0710514e897, content=偏重的研究方向：肿瘤 经验分享：这个投稿系统怎么撤稿呀，我们医院不给中科院预警杂志报销，想撤稿，这个系统里面没有撤稿选项怎么弄呀，有老师撤过稿吗？请教一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3085497237, createdName=陈陈陈陈陈, createdTime=Wed Sep 15 13:21:28 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187789, encodeId=5fb9118e789ce, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：速度中等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Mon Jan 24 19:37:36 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185703, encodeId=8cb31185e0359, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，两个多月，期间邮件咨询两次编辑一封邮件没有回，然后被系统直接拒稿，也没给任何外审建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34225191461, createdName=14719ffem18(暂无昵称), createdTime=Tue Jan 18 19:11:24 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179230, encodeId=b05711e92304c, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 American Journal of Translational Research (AJTR)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:02:19 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970174, encodeId=30299e0174b8, content=荣登2020年11月20日中山大学附属第一医院不予医院经费支持与鼓励的期刊目录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b9e5511146, createdName=JasonTrue, createdTime=Tue Jun 01 21:44:29 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977541, encodeId=09c29e7541ae, content=接受个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 11:23:00 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2022-01-11 1471fd32m50暂无昵称

有老哥知道吗，为啥一提交，直接显示under review啊,没有编辑处理的过程吗

117 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1183089, encodeId=a0ca118308919, content=有老哥知道吗，为啥一提交，直接显示under review啊,没有编辑处理的过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9925193263, createdName=1471fd32m50暂无昵称, createdTime=Tue Jan 11 08:57:31 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238801, encodeId=c12c123880186, content=有哪位前辈分享一下微生物临床研究Q3的2-3分的杂志啊，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66495497077, createdName=Ysbstsvshndudnd, createdTime=Mon Aug 15 14:41:37 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222243, encodeId=7f7b1222243e5, content=审稿速度:3.0 | 投稿命中率:50.0 | 影响因子:4.06 偏重的研究方向：肿瘤免疫微环境;肿瘤;免疫检查点 经验分享：经历8个月，修了2次，因为疫情耽误了2个月，发了4次Reminder letter，昨天接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f425184724, createdName=14704397m27暂无昵称, createdTime=Wed May 25 08:58:04 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969139, encodeId=ad1196913910, content=生信期刊收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epbiavQw9picXSMXa5H7ZG9oW2IUumIqEJffFK1qfw7FS2XODCYRNmp6YlLwywwIZ2zxRVfGY0XHEnw/132, createdBy=67992544404, createdName=哈哈娜, createdTime=Fri May 28 10:54:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051478, encodeId=fa0710514e897, content=偏重的研究方向：肿瘤 经验分享：这个投稿系统怎么撤稿呀，我们医院不给中科院预警杂志报销，想撤稿，这个系统里面没有撤稿选项怎么弄呀，有老师撤过稿吗？请教一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3085497237, createdName=陈陈陈陈陈, createdTime=Wed Sep 15 13:21:28 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187789, encodeId=5fb9118e789ce, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：速度中等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Mon Jan 24 19:37:36 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185703, encodeId=8cb31185e0359, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，两个多月，期间邮件咨询两次编辑一封邮件没有回，然后被系统直接拒稿，也没给任何外审建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34225191461, createdName=14719ffem18(暂无昵称), createdTime=Tue Jan 18 19:11:24 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179230, encodeId=b05711e92304c, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 American Journal of Translational Research (AJTR)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:02:19 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970174, encodeId=30299e0174b8, content=荣登2020年11月20日中山大学附属第一医院不予医院经费支持与鼓励的期刊目录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b9e5511146, createdName=JasonTrue, createdTime=Tue Jun 01 21:44:29 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977541, encodeId=09c29e7541ae, content=接受个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 11:23:00 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2022-08-15 Ysbstsvshndudnd

有哪位前辈分享一下微生物临床研究Q3的2-3分的杂志啊，谢谢

54 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1183089, encodeId=a0ca118308919, content=有老哥知道吗，为啥一提交，直接显示under review啊,没有编辑处理的过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9925193263, createdName=1471fd32m50暂无昵称, createdTime=Tue Jan 11 08:57:31 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238801, encodeId=c12c123880186, content=有哪位前辈分享一下微生物临床研究Q3的2-3分的杂志啊，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66495497077, createdName=Ysbstsvshndudnd, createdTime=Mon Aug 15 14:41:37 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222243, encodeId=7f7b1222243e5, content=审稿速度:3.0 | 投稿命中率:50.0 | 影响因子:4.06 偏重的研究方向：肿瘤免疫微环境;肿瘤;免疫检查点 经验分享：经历8个月，修了2次，因为疫情耽误了2个月，发了4次Reminder letter，昨天接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f425184724, createdName=14704397m27暂无昵称, createdTime=Wed May 25 08:58:04 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969139, encodeId=ad1196913910, content=生信期刊收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epbiavQw9picXSMXa5H7ZG9oW2IUumIqEJffFK1qfw7FS2XODCYRNmp6YlLwywwIZ2zxRVfGY0XHEnw/132, createdBy=67992544404, createdName=哈哈娜, createdTime=Fri May 28 10:54:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051478, encodeId=fa0710514e897, content=偏重的研究方向：肿瘤 经验分享：这个投稿系统怎么撤稿呀，我们医院不给中科院预警杂志报销，想撤稿，这个系统里面没有撤稿选项怎么弄呀，有老师撤过稿吗？请教一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3085497237, createdName=陈陈陈陈陈, createdTime=Wed Sep 15 13:21:28 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187789, encodeId=5fb9118e789ce, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：速度中等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Mon Jan 24 19:37:36 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185703, encodeId=8cb31185e0359, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，两个多月，期间邮件咨询两次编辑一封邮件没有回，然后被系统直接拒稿，也没给任何外审建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34225191461, createdName=14719ffem18(暂无昵称), createdTime=Tue Jan 18 19:11:24 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179230, encodeId=b05711e92304c, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 American Journal of Translational Research (AJTR)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:02:19 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970174, encodeId=30299e0174b8, content=荣登2020年11月20日中山大学附属第一医院不予医院经费支持与鼓励的期刊目录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b9e5511146, createdName=JasonTrue, createdTime=Tue Jun 01 21:44:29 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977541, encodeId=09c29e7541ae, content=接受个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 11:23:00 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2022-05-25 14704397m27暂无昵称

审稿速度:3.0 | 投稿命中率:50.0 | 影响因子:4.06
偏重的研究方向：肿瘤免疫微环境;肿瘤;免疫检查点
经验分享：经历8个月，修了2次，因为疫情耽误了2个月，发了4次Reminder letter，昨天接受了

89 0

[GetPortalCommentsPageByObjectIdResponse(id=1183089, encodeId=a0ca118308919, content=有老哥知道吗，为啥一提交，直接显示under review啊,没有编辑处理的过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9925193263, createdName=1471fd32m50暂无昵称, createdTime=Tue Jan 11 08:57:31 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238801, encodeId=c12c123880186, content=有哪位前辈分享一下微生物临床研究Q3的2-3分的杂志啊，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66495497077, createdName=Ysbstsvshndudnd, createdTime=Mon Aug 15 14:41:37 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222243, encodeId=7f7b1222243e5, content=审稿速度:3.0 | 投稿命中率:50.0 | 影响因子:4.06 偏重的研究方向：肿瘤免疫微环境;肿瘤;免疫检查点 经验分享：经历8个月，修了2次，因为疫情耽误了2个月，发了4次Reminder letter，昨天接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f425184724, createdName=14704397m27暂无昵称, createdTime=Wed May 25 08:58:04 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969139, encodeId=ad1196913910, content=生信期刊收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epbiavQw9picXSMXa5H7ZG9oW2IUumIqEJffFK1qfw7FS2XODCYRNmp6YlLwywwIZ2zxRVfGY0XHEnw/132, createdBy=67992544404, createdName=哈哈娜, createdTime=Fri May 28 10:54:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051478, encodeId=fa0710514e897, content=偏重的研究方向：肿瘤 经验分享：这个投稿系统怎么撤稿呀，我们医院不给中科院预警杂志报销，想撤稿，这个系统里面没有撤稿选项怎么弄呀，有老师撤过稿吗？请教一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3085497237, createdName=陈陈陈陈陈, createdTime=Wed Sep 15 13:21:28 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187789, encodeId=5fb9118e789ce, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：速度中等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Mon Jan 24 19:37:36 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185703, encodeId=8cb31185e0359, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，两个多月，期间邮件咨询两次编辑一封邮件没有回，然后被系统直接拒稿，也没给任何外审建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34225191461, createdName=14719ffem18(暂无昵称), createdTime=Tue Jan 18 19:11:24 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179230, encodeId=b05711e92304c, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 American Journal of Translational Research (AJTR)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:02:19 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970174, encodeId=30299e0174b8, content=荣登2020年11月20日中山大学附属第一医院不予医院经费支持与鼓励的期刊目录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b9e5511146, createdName=JasonTrue, createdTime=Tue Jun 01 21:44:29 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977541, encodeId=09c29e7541ae, content=接受个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 11:23:00 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2021-05-28 哈哈娜

生信期刊收吗？

313 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1183089, encodeId=a0ca118308919, content=有老哥知道吗，为啥一提交，直接显示under review啊,没有编辑处理的过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9925193263, createdName=1471fd32m50暂无昵称, createdTime=Tue Jan 11 08:57:31 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238801, encodeId=c12c123880186, content=有哪位前辈分享一下微生物临床研究Q3的2-3分的杂志啊，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66495497077, createdName=Ysbstsvshndudnd, createdTime=Mon Aug 15 14:41:37 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222243, encodeId=7f7b1222243e5, content=审稿速度:3.0 | 投稿命中率:50.0 | 影响因子:4.06 偏重的研究方向：肿瘤免疫微环境;肿瘤;免疫检查点 经验分享：经历8个月，修了2次，因为疫情耽误了2个月，发了4次Reminder letter，昨天接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f425184724, createdName=14704397m27暂无昵称, createdTime=Wed May 25 08:58:04 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969139, encodeId=ad1196913910, content=生信期刊收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epbiavQw9picXSMXa5H7ZG9oW2IUumIqEJffFK1qfw7FS2XODCYRNmp6YlLwywwIZ2zxRVfGY0XHEnw/132, createdBy=67992544404, createdName=哈哈娜, createdTime=Fri May 28 10:54:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051478, encodeId=fa0710514e897, content=偏重的研究方向：肿瘤 经验分享：这个投稿系统怎么撤稿呀，我们医院不给中科院预警杂志报销，想撤稿，这个系统里面没有撤稿选项怎么弄呀，有老师撤过稿吗？请教一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3085497237, createdName=陈陈陈陈陈, createdTime=Wed Sep 15 13:21:28 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187789, encodeId=5fb9118e789ce, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：速度中等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Mon Jan 24 19:37:36 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185703, encodeId=8cb31185e0359, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，两个多月，期间邮件咨询两次编辑一封邮件没有回，然后被系统直接拒稿，也没给任何外审建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34225191461, createdName=14719ffem18(暂无昵称), createdTime=Tue Jan 18 19:11:24 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179230, encodeId=b05711e92304c, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 American Journal of Translational Research (AJTR)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:02:19 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970174, encodeId=30299e0174b8, content=荣登2020年11月20日中山大学附属第一医院不予医院经费支持与鼓励的期刊目录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b9e5511146, createdName=JasonTrue, createdTime=Tue Jun 01 21:44:29 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977541, encodeId=09c29e7541ae, content=接受个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 11:23:00 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2021-09-15 陈陈陈陈陈

偏重的研究方向：肿瘤
经验分享：这个投稿系统怎么撤稿呀，我们医院不给中科院预警杂志报销，想撤稿，这个系统里面没有撤稿选项怎么弄呀，有老师撤过稿吗？请教一下。

119 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1183089, encodeId=a0ca118308919, content=有老哥知道吗，为啥一提交，直接显示under review啊,没有编辑处理的过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9925193263, createdName=1471fd32m50暂无昵称, createdTime=Tue Jan 11 08:57:31 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238801, encodeId=c12c123880186, content=有哪位前辈分享一下微生物临床研究Q3的2-3分的杂志啊，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66495497077, createdName=Ysbstsvshndudnd, createdTime=Mon Aug 15 14:41:37 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222243, encodeId=7f7b1222243e5, content=审稿速度:3.0 | 投稿命中率:50.0 | 影响因子:4.06 偏重的研究方向：肿瘤免疫微环境;肿瘤;免疫检查点 经验分享：经历8个月，修了2次，因为疫情耽误了2个月，发了4次Reminder letter，昨天接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f425184724, createdName=14704397m27暂无昵称, createdTime=Wed May 25 08:58:04 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969139, encodeId=ad1196913910, content=生信期刊收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epbiavQw9picXSMXa5H7ZG9oW2IUumIqEJffFK1qfw7FS2XODCYRNmp6YlLwywwIZ2zxRVfGY0XHEnw/132, createdBy=67992544404, createdName=哈哈娜, createdTime=Fri May 28 10:54:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051478, encodeId=fa0710514e897, content=偏重的研究方向：肿瘤 经验分享：这个投稿系统怎么撤稿呀，我们医院不给中科院预警杂志报销，想撤稿，这个系统里面没有撤稿选项怎么弄呀，有老师撤过稿吗？请教一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3085497237, createdName=陈陈陈陈陈, createdTime=Wed Sep 15 13:21:28 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187789, encodeId=5fb9118e789ce, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：速度中等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Mon Jan 24 19:37:36 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185703, encodeId=8cb31185e0359, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，两个多月，期间邮件咨询两次编辑一封邮件没有回，然后被系统直接拒稿，也没给任何外审建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34225191461, createdName=14719ffem18(暂无昵称), createdTime=Tue Jan 18 19:11:24 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179230, encodeId=b05711e92304c, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 American Journal of Translational Research (AJTR)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:02:19 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970174, encodeId=30299e0174b8, content=荣登2020年11月20日中山大学附属第一医院不予医院经费支持与鼓励的期刊目录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b9e5511146, createdName=JasonTrue, createdTime=Tue Jun 01 21:44:29 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977541, encodeId=09c29e7541ae, content=接受个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 11:23:00 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2022-01-24 故乡的云

审稿速度:2.0 | 投稿命中率:95.0
经验分享：速度中等

98 0

[GetPortalCommentsPageByObjectIdResponse(id=1183089, encodeId=a0ca118308919, content=有老哥知道吗，为啥一提交，直接显示under review啊,没有编辑处理的过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9925193263, createdName=1471fd32m50暂无昵称, createdTime=Tue Jan 11 08:57:31 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238801, encodeId=c12c123880186, content=有哪位前辈分享一下微生物临床研究Q3的2-3分的杂志啊，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66495497077, createdName=Ysbstsvshndudnd, createdTime=Mon Aug 15 14:41:37 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222243, encodeId=7f7b1222243e5, content=审稿速度:3.0 | 投稿命中率:50.0 | 影响因子:4.06 偏重的研究方向：肿瘤免疫微环境;肿瘤;免疫检查点 经验分享：经历8个月，修了2次，因为疫情耽误了2个月，发了4次Reminder letter，昨天接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f425184724, createdName=14704397m27暂无昵称, createdTime=Wed May 25 08:58:04 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969139, encodeId=ad1196913910, content=生信期刊收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epbiavQw9picXSMXa5H7ZG9oW2IUumIqEJffFK1qfw7FS2XODCYRNmp6YlLwywwIZ2zxRVfGY0XHEnw/132, createdBy=67992544404, createdName=哈哈娜, createdTime=Fri May 28 10:54:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051478, encodeId=fa0710514e897, content=偏重的研究方向：肿瘤 经验分享：这个投稿系统怎么撤稿呀，我们医院不给中科院预警杂志报销，想撤稿，这个系统里面没有撤稿选项怎么弄呀，有老师撤过稿吗？请教一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3085497237, createdName=陈陈陈陈陈, createdTime=Wed Sep 15 13:21:28 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187789, encodeId=5fb9118e789ce, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：速度中等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Mon Jan 24 19:37:36 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185703, encodeId=8cb31185e0359, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，两个多月，期间邮件咨询两次编辑一封邮件没有回，然后被系统直接拒稿，也没给任何外审建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34225191461, createdName=14719ffem18(暂无昵称), createdTime=Tue Jan 18 19:11:24 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179230, encodeId=b05711e92304c, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 American Journal of Translational Research (AJTR)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:02:19 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970174, encodeId=30299e0174b8, content=荣登2020年11月20日中山大学附属第一医院不予医院经费支持与鼓励的期刊目录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b9e5511146, createdName=JasonTrue, createdTime=Tue Jun 01 21:44:29 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977541, encodeId=09c29e7541ae, content=接受个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 11:23:00 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2022-01-18 14719ffem18(暂无昵称)

审稿速度:3.0
偏重的研究方向：肿瘤
经验分享：垃圾杂志，两个多月，期间邮件咨询两次编辑一封邮件没有回，然后被系统直接拒稿，也没给任何外审建议。

49 0

[GetPortalCommentsPageByObjectIdResponse(id=1183089, encodeId=a0ca118308919, content=有老哥知道吗，为啥一提交，直接显示under review啊,没有编辑处理的过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9925193263, createdName=1471fd32m50暂无昵称, createdTime=Tue Jan 11 08:57:31 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238801, encodeId=c12c123880186, content=有哪位前辈分享一下微生物临床研究Q3的2-3分的杂志啊，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66495497077, createdName=Ysbstsvshndudnd, createdTime=Mon Aug 15 14:41:37 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222243, encodeId=7f7b1222243e5, content=审稿速度:3.0 | 投稿命中率:50.0 | 影响因子:4.06 偏重的研究方向：肿瘤免疫微环境;肿瘤;免疫检查点 经验分享：经历8个月，修了2次，因为疫情耽误了2个月，发了4次Reminder letter，昨天接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f425184724, createdName=14704397m27暂无昵称, createdTime=Wed May 25 08:58:04 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969139, encodeId=ad1196913910, content=生信期刊收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epbiavQw9picXSMXa5H7ZG9oW2IUumIqEJffFK1qfw7FS2XODCYRNmp6YlLwywwIZ2zxRVfGY0XHEnw/132, createdBy=67992544404, createdName=哈哈娜, createdTime=Fri May 28 10:54:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051478, encodeId=fa0710514e897, content=偏重的研究方向：肿瘤 经验分享：这个投稿系统怎么撤稿呀，我们医院不给中科院预警杂志报销，想撤稿，这个系统里面没有撤稿选项怎么弄呀，有老师撤过稿吗？请教一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3085497237, createdName=陈陈陈陈陈, createdTime=Wed Sep 15 13:21:28 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187789, encodeId=5fb9118e789ce, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：速度中等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Mon Jan 24 19:37:36 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185703, encodeId=8cb31185e0359, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，两个多月，期间邮件咨询两次编辑一封邮件没有回，然后被系统直接拒稿，也没给任何外审建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34225191461, createdName=14719ffem18(暂无昵称), createdTime=Tue Jan 18 19:11:24 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179230, encodeId=b05711e92304c, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 American Journal of Translational Research (AJTR)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:02:19 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970174, encodeId=30299e0174b8, content=荣登2020年11月20日中山大学附属第一医院不予医院经费支持与鼓励的期刊目录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b9e5511146, createdName=JasonTrue, createdTime=Tue Jun 01 21:44:29 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977541, encodeId=09c29e7541ae, content=接受个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 11:23:00 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2021-12-31 agile

偏重的研究方向：肿瘤
经验分享：2021年《国际期刊预警名单（试行）》正式发布。 American Journal of Translational Research (AJTR)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA

55 0

[GetPortalCommentsPageByObjectIdResponse(id=1183089, encodeId=a0ca118308919, content=有老哥知道吗，为啥一提交，直接显示under review啊,没有编辑处理的过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9925193263, createdName=1471fd32m50暂无昵称, createdTime=Tue Jan 11 08:57:31 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238801, encodeId=c12c123880186, content=有哪位前辈分享一下微生物临床研究Q3的2-3分的杂志啊，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66495497077, createdName=Ysbstsvshndudnd, createdTime=Mon Aug 15 14:41:37 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222243, encodeId=7f7b1222243e5, content=审稿速度:3.0 | 投稿命中率:50.0 | 影响因子:4.06 偏重的研究方向：肿瘤免疫微环境;肿瘤;免疫检查点 经验分享：经历8个月，修了2次，因为疫情耽误了2个月，发了4次Reminder letter，昨天接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f425184724, createdName=14704397m27暂无昵称, createdTime=Wed May 25 08:58:04 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969139, encodeId=ad1196913910, content=生信期刊收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epbiavQw9picXSMXa5H7ZG9oW2IUumIqEJffFK1qfw7FS2XODCYRNmp6YlLwywwIZ2zxRVfGY0XHEnw/132, createdBy=67992544404, createdName=哈哈娜, createdTime=Fri May 28 10:54:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051478, encodeId=fa0710514e897, content=偏重的研究方向：肿瘤 经验分享：这个投稿系统怎么撤稿呀，我们医院不给中科院预警杂志报销，想撤稿，这个系统里面没有撤稿选项怎么弄呀，有老师撤过稿吗？请教一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3085497237, createdName=陈陈陈陈陈, createdTime=Wed Sep 15 13:21:28 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187789, encodeId=5fb9118e789ce, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：速度中等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Mon Jan 24 19:37:36 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185703, encodeId=8cb31185e0359, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，两个多月，期间邮件咨询两次编辑一封邮件没有回，然后被系统直接拒稿，也没给任何外审建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34225191461, createdName=14719ffem18(暂无昵称), createdTime=Tue Jan 18 19:11:24 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179230, encodeId=b05711e92304c, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 American Journal of Translational Research (AJTR)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:02:19 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970174, encodeId=30299e0174b8, content=荣登2020年11月20日中山大学附属第一医院不予医院经费支持与鼓励的期刊目录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b9e5511146, createdName=JasonTrue, createdTime=Tue Jun 01 21:44:29 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977541, encodeId=09c29e7541ae, content=接受个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 11:23:00 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2021-06-01 JasonTrue

荣登2020年11月20日中山大学附属第一医院不予医院经费支持与鼓励的期刊目录

70 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1183089, encodeId=a0ca118308919, content=有老哥知道吗，为啥一提交，直接显示under review啊,没有编辑处理的过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9925193263, createdName=1471fd32m50暂无昵称, createdTime=Tue Jan 11 08:57:31 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238801, encodeId=c12c123880186, content=有哪位前辈分享一下微生物临床研究Q3的2-3分的杂志啊，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66495497077, createdName=Ysbstsvshndudnd, createdTime=Mon Aug 15 14:41:37 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222243, encodeId=7f7b1222243e5, content=审稿速度:3.0 | 投稿命中率:50.0 | 影响因子:4.06 偏重的研究方向：肿瘤免疫微环境;肿瘤;免疫检查点 经验分享：经历8个月，修了2次，因为疫情耽误了2个月，发了4次Reminder letter，昨天接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f425184724, createdName=14704397m27暂无昵称, createdTime=Wed May 25 08:58:04 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969139, encodeId=ad1196913910, content=生信期刊收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epbiavQw9picXSMXa5H7ZG9oW2IUumIqEJffFK1qfw7FS2XODCYRNmp6YlLwywwIZ2zxRVfGY0XHEnw/132, createdBy=67992544404, createdName=哈哈娜, createdTime=Fri May 28 10:54:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051478, encodeId=fa0710514e897, content=偏重的研究方向：肿瘤 经验分享：这个投稿系统怎么撤稿呀，我们医院不给中科院预警杂志报销，想撤稿，这个系统里面没有撤稿选项怎么弄呀，有老师撤过稿吗？请教一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3085497237, createdName=陈陈陈陈陈, createdTime=Wed Sep 15 13:21:28 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187789, encodeId=5fb9118e789ce, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：速度中等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1f81641983, createdName=故乡的云, createdTime=Mon Jan 24 19:37:36 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185703, encodeId=8cb31185e0359, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，两个多月，期间邮件咨询两次编辑一封邮件没有回，然后被系统直接拒稿，也没给任何外审建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34225191461, createdName=14719ffem18(暂无昵称), createdTime=Tue Jan 18 19:11:24 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179230, encodeId=b05711e92304c, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 American Journal of Translational Research (AJTR)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:02:19 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970174, encodeId=30299e0174b8, content=荣登2020年11月20日中山大学附属第一医院不予医院经费支持与鼓励的期刊目录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b9e5511146, createdName=JasonTrue, createdTime=Tue Jun 01 21:44:29 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977541, encodeId=09c29e7541ae, content=接受个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 11:23:00 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2021-06-28 ms1000000940702777

接受个案吗？

59 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务